Rheumatoid Arthritis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with rheumatoid arthritis (RA) who meet the 2010 ACR/EULAR classification criteria or the 1987 ACR classification criteria for RA, with low to moderate disease activity (CDAI 2.8-22.0), and who have been relatively stable with no changes in antirheumatic therapy for at least 3 months.
Exclusion criteria
Exclusion criteria: Patients scheduled for changes in antirheumatic therapy (addition or dose escalation)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change rate of the CDAI score at 1 month | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in Pain VAS and Patient Global Assessment at 0.5, 1, 3, 6, and 12 months following treatment initiation | — |
Countries
Japan
Contacts
Kobe City Medical Center General Hospital Department of Rheumatology